Dow Up 0.68% Nasdaq Up 1.67%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.70 Down 0.01(1.59%) 11:09AM EDT - Nasdaq Real Time Price
Prev Close:0.72
Open:0.70
Bid:0.70 x 400
Ask:0.71 x 900
1y Target Est:3.50
Beta:0.94
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:0.70 - 0.72
52wk Range:0.65 - 4.00
Volume:48,413
Avg Vol (3m):341,194
Market Cap:42.69M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCDown 1.59%42.69M
AGENUp 0.67%188.04M
DNDNUp 1.33%177.97M
STMLDown 3.48%165.06M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback